TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP)

Historical Holders from Q1 2014 to Q3 2017

Type / Class
Equity / COM NEW
Symbol
TNXP on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2017 Q3 0 $0 -$1,602,000 0
2017 Q2 370,000 $1,602,000 +$194,514 $4.33 1
2017 Q1 318,510 $1,487,000 -$2,999,458 $4.67 3
2016 Q4 2,775,463 $1,302,258 -$775,371 $0.47 23
2016 Q3 4,011,964 $2,794,000 -$7,613,799 $0.70 33
2016 Q2 8,727,075 $17,365,740 +$780,558 $1.99 46
2016 Q1 8,007,807 $19,293,000 -$10,630,755 $2.41 47
2015 Q4 9,161,514 $70,265,000 +$215,822 $7.67 48
2015 Q3 9,237,332 $48,865,000 +$8,804,991 $5.29 49
2015 Q2 7,442,329 $66,697,000 +$8,406,975 $8.97 45
2015 Q1 6,482,071 $40,966,000 +$22,891,246 $6.32 30
2014 Q4 2,863,047 $16,716,000 +$635,508 $5.84 28
2014 Q3 2,724,811 $18,638,020 +$140,775 $6.85 25
2014 Q2 2,584,226 $37,073,960 -$5,592,430 $14.35 17
2014 Q1 3,076,248 $32,019,000 +$24,720,607 $10.41 21